- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03937557
The Analysis of Hair Count in Healthy Taiwanese Persons by Trichoscope
December 30, 2019 updated by: Chu Gong Yau, Shin Kong Wu Ho-Su Memorial Hospital
Horizontal sectioning of scalp biopsy is a better method for evaluating hair disorders than vertical sectioning because it enables the quantitative examination of hair follicles at different stages.
Without having the quantitative data of normal scalp hair counts as controls, it is impossible to evaluate scalp biopsies for hair disorders.
In recent years, trichoscope is more popular in analysis of hair disease.
It is less invasive and simple.
The aim of this study is to understand the pros and cons of trichoscpoe.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 50 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 20-50y/o adults without any scalp disorder
Exclusion Criteria:
- adults with any scalp disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: men's hair count
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam and compare the pros and cons with the data from scalp biopsy.
|
PLACEBO_COMPARATOR: women's hair count
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam and compare the pros and cons with the data from scalp biopsy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average number of hairs
Time Frame: 1 year
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average hair shaft thickness
Time Frame: 1 year
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam
|
1 year
|
Amount of Single, double and riple follicular unit
Time Frame: 1year
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam
|
1year
|
Amount of Empty hair follicles
Time Frame: 1 year
|
Exam frontal, bilateral Temporal and occipital scalp by photofinder levicam
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 5, 2019
Primary Completion (ANTICIPATED)
April 5, 2020
Study Completion (ANTICIPATED)
April 22, 2020
Study Registration Dates
First Submitted
April 29, 2019
First Submitted That Met QC Criteria
May 1, 2019
First Posted (ACTUAL)
May 3, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 2, 2020
Last Update Submitted That Met QC Criteria
December 30, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20190202R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dermatosis
-
Wake Forest UniversityCompletedHand DermatosisUnited States
-
Dong-A UniversityCompletedActinic DermatosisKorea, Republic of
-
University Hospital, MontpellierIntegraGen SANot yet recruitingPigmentary; Dermatosis
-
CHU de ReimsCompletedErosive Pustular Dermatosis of the LegFrance
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
DermBiont, Inc.RecruitingDermatosis Papulosa NigraUnited States
-
Aclaris Therapeutics, Inc.CompletedDermatosis Papulosa NigraUnited States
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompletedHand DermatosisUnited States
-
Premier Specialists, AustraliaSteritasActive, not recruitingGlucocorticoids Toxicity | Autoimmune Bullous DermatosisAustralia
-
Dong-A UniversityCompletedActinic DermatosisKorea, Republic of